Extended Access Program With Lorcaserin For The Treatment of Dravet Syndrome and Other Refractory Epilepsies

ClinicalTrials.gov ID: NCT04457687

Public ClinicalTrials.gov record NCT04457687. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 22, 2026, 10:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Extended Access Program and Retrospective Chart Review for Lorcaserin in Dravet Syndrome and Other Refractory Epilepsies

Study identification

NCT ID: NCT04457687
Recruitment status: Available
Study type: Expanded access
Phase: Not listed
Lead sponsor: Eisai Inc.; Industry
Enrollment: Not listed

Conditions and interventions

Conditions

Interventions

Lorcaserin Drug

Drug

Eligibility (public fields only)

Age range: 2 Years and older
Sex: All
Healthy volunteers: Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Not listed
Primary completion: Not listed
Completion: Not listed
Last update posted: Jan 29, 2025

United States locations

U.S. sites: 18
U.S. states: 13
U.S. cities: 17

Facility	City	State	ZIP	Site status
University of Alabama at Birmingham	Birmingham	Alabama	35233	Available
David Geffen School of Medicine, UCLA Mattel Children's Hospital	Los Angeles	California	90095	Available
Children's Hospital Colorado	Aurora	Colorado	80045	Available
Pena	Avon	Connecticut	06001	Available
(Resor)	Greenwich	Connecticut	06830	Available
Children's National Medical Center	Washington D.C.	District of Columbia	20019	Available
Clinical Neurosciences of Tampa Bay	Clearwater	Florida	33764	Available
Miami Children's Hospital - Nicklaus Children's Hospital Miami	Miami	Florida	33155	Available
Mid-Atlantic Epilepsy and Sleep Center - Bethesda	Bethesda	Maryland	20817	Available
University of Missouri Health Care	Columbia	Missouri	65212	Available
Northeastern Regional Epilepsy Group (Hackensack)	Hackensack	New Jersey	07601	Available
New York Medical College	Hawthorne	New York	10532	Available
NYU Langone Comprehensive Epilepsy Center	New York	New York	10016	Available
Mt. Sinai School of Medicine	New York	New York	10029	Available
University Hospital Cleveland Medical Center	Cleveland	Ohio	44106	Available
Sidney Kimmel Medical College at Thomas Jefferson University	Philadelphia	Pennsylvania	19107	Available
Children's Hospital of Pittsburgh of UPMC	Pittsburgh	Pennsylvania	15224	Available
The University of Texas Health Science Center at Houston	Houston	Texas	77030	Available

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04457687, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 29, 2025 · Synced Jul 22, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04457687 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →